BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin KT, Du WL, Lan HR, Liu YY, Mao CS, Du JL, Mou XZ. Development of humanized mouse with patient-derived xenografts for cancer immunotherapy studies: A comprehensive review. Cancer Sci 2021;112:2592-606. [PMID: 33938090 DOI: 10.1111/cas.14934] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Chan YS, Wong K, Yoshitake R, Sadava D, Synold T, Frankel P, Twardowski PW, Lau C, Chen S. Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials. Cancers 2023;15:701. [DOI: 10.3390/cancers15030701] [Reference Citation Analysis]
2 Chuprin J, Buettner H, Seedhom MO, Greiner DL, Keck JG, Ishikawa F, Shultz LD, Brehm MA. Humanized mouse models for immuno-oncology research. Nat Rev Clin Oncol 2023. [PMID: 36635480 DOI: 10.1038/s41571-022-00721-2] [Reference Citation Analysis]
3 Tanaka T, Nishie R, Ueda S, Miyamoto S, Hashida S, Konishi H, Terada S, Kogata Y, Sasaki H, Tsunetoh S, Taniguchi K, Komura K, Ohmichi M. Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review. JCM 2022;11:2606. [DOI: 10.3390/jcm11092606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bruss C, Kellner K, Ortmann O, Seitz S, Brockhoff G, Hutchinson JA, Wege AK. Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice. Cancers (Basel) 2022;14:2214. [PMID: 35565343 DOI: 10.3390/cancers14092214] [Reference Citation Analysis]
5 Tsang SI, Hassan AA, To SK, Wong AS. Experimental models for ovarian cancer research. Experimental Cell Research 2022. [DOI: 10.1016/j.yexcr.2022.113150] [Reference Citation Analysis]
6 You K, Wang P, Ho D. N-of-1 Healthcare: Challenges and Prospects for the Future of Personalized Medicine. Front Digit Health 2022;4:830656. [DOI: 10.3389/fdgth.2022.830656] [Reference Citation Analysis]
7 Pial MMH, Tomitaka A, Pala N, Roy U. Implantable Devices for the Treatment of Breast Cancer. JNT 2022;3:19-38. [DOI: 10.3390/jnt3010003] [Reference Citation Analysis]
8 Mondal P, Bailey KL, Cartwright SB, Band V, Carlson MA. Large Animal Models of Breast Cancer. Front Oncol 2022;12:788038. [PMID: 35186735 DOI: 10.3389/fonc.2022.788038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
9 Seidah NG, Prat A. The multifaceted biology of PCSK9. Endocr Rev 2021:bnab035. [PMID: 34626468 DOI: 10.1210/endrev/bnab035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
10 Tanaka T, Nishie R, Ueda S, Miyamoto S, Hashida S, Konishi H, Terada S, Kogata Y, Sasaki H, Tsunetoh S, Taniguchi K, Komura K, Ohmichi M. Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review. Int J Mol Sci 2021;22:9369. [PMID: 34502278 DOI: 10.3390/ijms22179369] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Jin KT, Du WL, Lan HR, Liu YY, Mao CS, Du JL, Mou XZ. Development of humanized mouse with patient-derived xenografts for cancer immunotherapy studies: A comprehensive review. Cancer Sci 2021;112:2592-606. [PMID: 33938090 DOI: 10.1111/cas.14934] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]